|
Originally published In Press as doi:10.1074/jbc.M201056200 on February 12, 2002
J. Biol. Chem., Vol. 277, Issue 17, 14764-14770, April 26, 2002
Kinetic Characterization of Human Glutamine-fructose-6-phosphate
Amidotransferase I
POTENT FEEDBACK INHIBITION BY GLUCOSAMINE 6-PHOSPHATE*
Kay O.
Broschat §,
Christine
Gorka ,
Jimmy D.
Page¶,
Cynthia L.
Martin-Berger¶,
Michael S.
Davies ,
Horng-chih
Huang**,
Eric A.
Gulve ,
William J.
Salsgiver , and
Thomas P.
Kasten
From the Cardiovascular & Metabolic Disesases,
Pharmacia Corporation, St. Louis, Missouri 63167, ¶ Discovery
Biology, Pharmacia Corporation, Skokie, Illinois 60077, and
Biochemistry & Molecular Biology and ** Discovery
Chemistry, Pharmacia Corporation, Chesterfield, Missouri 63198
Glutamine-fructose-6-phosphate amidotransferase
(GFAT) catalyzes the first committed step in the pathway for
biosynthesis of hexosamines in mammals. A member of the
N-terminal nucleophile class of amidotransferases, GFAT transfers the
amino group from the L-glutamine amide to
D-fructose 6-phosphate, producing glutamic acid and
glucosamine 6-phosphate. The kinetic constants reported previously for
mammalian GFAT implicate a relatively low affinity for the acceptor
substrate, fructose 6-phosphate (Fru-6-P, Km 0.2-1
mM). Utilizing a new sensitive assay that measures
the production of glucosamine 6-phosphate (GlcN-6-P), purified
recombinant human GFAT1 (hGFAT1) exhibited a Km for
Fru-6-P of 7 µM, and was highly sensitive to product
inhibition by GlcN-6-P. In a second assay method that measures the
stimulation of glutaminase activity, a Kd of 2 µM was measured for Fru-6-P binding to hGFAT1. Further,
we report that the product, GlcN-6-P, is a potent competitive inhibitor
for the Fru-6-P site, with a Ki measured of 6 µM. Unlike other members of the amidotransferase family,
where glutamate production is loosely coupled to amide transfer, we have demonstrated that hGFAT1 production of glutamate and GlcN-6-P are
strictly coupled in the absence of inhibitors. Similar to other
amidotransferases, competitive inhibitors that bind at the synthase
site may inhibit the synthase activity without inhibiting the
glutaminase activity at the hydrolase domain. GlcN-6-P, for example,
inhibited the transfer reaction while fully activating the glutaminase
activity at the hydrolase domain. Inhibition of hGFAT1 by the end
product of the pathway, UDP-GlcNAc, was competitive with a
Ki of 4 µM. These data suggest that
hGFAT1 is fully active at physiological levels of Fru-6-P and may be
regulated by its product GlcN-6-P in addition to the pathway end
product, UDP-GlcNAc.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Cardiovascular and
Metabolic Diseases, Pharmacia Corp. T2M, 800 N. Lindbergh Blvd., St.
Louis, MO 63167. Tel.: 314-694-8988; Fax: 314-694-5216; E-mail: kay.o.broschat@pharmacia.com.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Eguchi, N. Oshiro, T. Miyamoto, K.-i. Yoshino, S. Okamoto, T. Ono, U. Kikkawa, and K. Yonezawa
AMP-activated protein kinase phosphorylates glutamine : fructose-6-phosphate amidotransferase 1 at Ser243 to modulate its enzymatic activity.
Genes Cells,
February 1, 2009;
14(2):
179 - 189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S Lau and J. W Dennis
N-Glycans in cancer progression
Glycobiology,
October 1, 2008;
18(10):
750 - 760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Grigorian, S.-U. Lee, W. Tian, I.-J. Chen, G. Gao, R. Mendelsohn, J. W. Dennis, and M. Demetriou
Control of T Cell-mediated Autoimmunity by Metabolite Flux to N-Glycan Biosynthesis
J. Biol. Chem.,
July 6, 2007;
282(27):
20027 - 20035.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Tanaka, F. Takahashi, T. Fukui, S. Fujiwara, H. Atomi, and T. Imanaka
Characterization of a Novel Glucosamine-6-Phosphate Deaminase from a Hyperthermophilic Archaeon
J. Bacteriol.,
October 15, 2005;
187(20):
7038 - 7044.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Marshall, O. Nadeau, and K. Yamasaki
Glucosamine-induced Activation of Glycogen Biosynthesis in Isolated Adipocytes: EVIDENCE FOR A RAPID ALLOSTERIC CONTROL MECHANISM WITHIN THE HEXOSAMINE BIOSYNTHESIS PATHWAY
J. Biol. Chem.,
March 25, 2005;
280(12):
11018 - 11024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hu, L. Riesland, A. J. Paterson, and J. E. Kudlow
Phosphorylation of Mouse Glutamine-Fructose-6-phosphate Amidotransferase 2 (GFAT2) by cAMP-dependent Protein Kinase Increases the Enzyme Activity
J. Biol. Chem.,
July 16, 2004;
279(29):
29988 - 29993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Vocadlo, H. C. Hang, E.-J. Kim, J. A. Hanover, and C. R. Bertozzi
A chemical approach for identifying O-GlcNAc-modified proteins in cells
PNAS,
August 5, 2003;
100(16):
9116 - 9121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Weigert, K. Klopfer, C. Kausch, K. Brodbeck, M. Stumvoll, H. U. Haring, and E. D. Schleicher
Palmitate-Induced Activation of the Hexosamine Pathway in Human Myotubes: Increased Expression of Glutamine:Fructose-6-Phosphate Aminotransferase
Diabetes,
March 1, 2003;
52(3):
650 - 656.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|